Side-by-side comparison of AI visibility scores, market position, and capabilities
Multispecialty pediatric provider integrating ABA, speech, OT, and medical care for autism and neurodevelopmental conditions. $80M raised Nov 2024; value-based care partnerships.
Cortica is a multispecialty pediatric healthcare organization delivering integrated care for children with autism and other neurodevelopmental disorders. Founded in 2017, the company combines applied behavior analysis (ABA), speech-language therapy, occupational therapy, physical therapy, music therapy, and medical services — including gene sequencing, metabolic testing, EEG, nutrition evaluation, and medication management — under one clinical model. This whole-child approach differentiates Cortica from single-discipline ABA providers and positions it closer to an academic health system model for autism. Cortica raised $80M in November 2024 and is entering value-based care arrangements with payors. The company operates centers across multiple U.S. states and is expanding its service model to include adolescents and adults, addressing a significant gap in the autism care continuum.
Noom is a digital weight health program combining psychology-based behavioral coaching, food logging, and human coaching to help members build sustainable healthy habits.
Noom is a digital health company founded in 2008 that has grown into one of the most widely used weight management platforms, serving millions of members through its psychology-driven approach to behavior change. The platform combines daily lessons on cognitive behavioral techniques, food logging with a traffic-light color-coding system, personal coaching from trained health coaches, and group support to help members change their relationship with food and exercise. Noom raised over $540M and reached a $3.7B valuation, establishing it as a leading consumer digital health company. The company has expanded beyond weight loss into a broader weight health platform addressing both weight management and weight-related conditions including type 2 diabetes management with its Noom Med offering that includes GLP-1 medication prescribing. As GLP-1 medications like Ozempic and Wegovy have transformed the weight loss market, Noom has positioned its behavioral coaching as essential to sustainable results alongside medication. The platform serves both direct-to-consumer subscribers and employer health plans that offer Noom as a weight management benefit for their workforces.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.